Skip to main content


EpiPen price relief could come from rivals before politicians

Mylan's EpiPen continues to dominate the market as a one-time rival looks to come back.

These 5 under-$10 stocks are set to soar higher

These under-$10 stocks look poised to break out and trade higher from current levels.

These 7 stocks under $10 are set to soar higher. Here's how to trade them.

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Biotech Sector Performance February 2014: Red Hot But...

An epic month of biotech stock performance ends with a significant sell off.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.